Jennison Associates
KYNB

Jennison Associates’s Kyntra Bio KYNB Stock Holding History

Jennison Associates’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,014
Closed -$28.6M – 659
2019
Q1 		$28.6M Sell
21,014
-249
-1% -$338K 0.03% 300
2018
Q4 		$24.6M Buy
21,263
+120
+0.6% +$135K 0.03% 321
2018
Q3 		$32.1M Buy
21,143
+89
+0.4% +$137K 0.03% 326
2018
Q2 		$32.9M Buy
21,054
+8,052
+62% +$10.5M 0.03% 330
2018
Q1 		$15M Buy
13,002
+1,925
+17% +$2.54M 0.01% 424
2017
Q4 		$13.1M Buy
11,077
+2,077
+23% +$2.6M 0.01% 446
2017
Q3 		$12.1M Buy
+9,000
New +$9.48M 0.01% 462

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jennison Associates's KYNB Position: Q2 2019 in Review

Jennison Associates sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 21,014 shares — an estimated $28.6M sold.

Jennison Associates first reported a position in KYNB in Q3 2017 and held it in 7 quarters. The position peaked at $32.9M in Q2 2018. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Jennison Associates reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Jennison Associates sold 21,014 Kyntra Bio shares in Q2 2019, an estimated $28.6M.
  • Jennison Associates first reported a position in Kyntra Bio in Q3 2017 and held it in 7 quarters.
  • Jennison Associates's Kyntra Bio position peaked at $32.9M in Q2 2018.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Jennison Associates's 13F filing for Q2 2019, filed 6 Aug 2019.